Literature DB >> 27257997

Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms.

Pierre-Joseph Royer1, Gustavo Olivera-Botello, Angela Koutsokera, John-David Aubert, Eric Bernasconi, Adrien Tissot, Christophe Pison, Laurent Nicod, Jean-Pierre Boissel, Antoine Magnan.   

Abstract

Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans syndrome or the recently described restrictive allograft syndrome. Although numerous risk factors have been identified so far, the physiopathological mechanisms of CLAD remain poorly understood. We investigate here the immune mechanisms involved in the development of CLAD after lung transplantation. We explore the innate or adaptive immune reactions induced by the allograft itself or by the environment and how they lead to allograft dysfunction. Because current literature suggests bronchiolitis obliterans syndrome and restrictive allograft syndrome as 2 distinct entities, we focus on the specific factors behind one or the other syndromes. Chronic lung allograft dysfunction is a multifactorial disease that remains irreversible and unpredictable so far. We thus finally discuss the potential of systems-biology approach to predict its occurrence and to better understand its underlying mechanisms.

Entities:  

Mesh:

Year:  2016        PMID: 27257997     DOI: 10.1097/TP.0000000000001215

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  25 in total

1.  [Lung transplantation : Histomorphological diagnosis and clinical aspects].

Authors:  J Wohlschlaeger; F Laenger; J Gottlieb; T Hager; A Seidel; D Jonigk
Journal:  Pathologe       Date:  2019-05       Impact factor: 1.011

2.  Detection of lung transplant rejection in a rat model using hyperpolarized [1-13 C] pyruvate-based metabolic imaging.

Authors:  Sarmad Siddiqui; Andreas Habertheuer; Yi Xin; Mehrdad Pourfathi; Jian-Qin Tao; Hooman Hamedani; Stephen Kadlecek; Ian Duncan; Prashanth Vallabhajosyula; Ali Naji; Shampa Chatterjee; Rahim Rizi
Journal:  NMR Biomed       Date:  2019-05-21       Impact factor: 4.044

3.  Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation.

Authors:  Vaidehi Kaza; Chengsong Zhu; Leying Feng; Fernando Torres; Srinivas Bollineni; Manish Mohanka; Amit Banga; John Joerns; T Mohanakumar; Lance S Terada; Quan-Zhen Li
Journal:  Transpl Immunol       Date:  2020-01-30       Impact factor: 1.708

4.  Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.

Authors:  Lynn D Haynes; Walker A Julliard; Joshua D Mezrich; Glen Leverson; Keith C Meyer; William J Burlingham
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

5.  Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Authors:  Natalia F Smirnova; Thomas M Conlon; Carmela Morrone; Peter Dorfmuller; Marc Humbert; Georgios T Stathopoulos; Stephan Umkehrer; Franz Pfeiffer; Ali Ö Yildirim; Oliver Eickelberg
Journal:  JCI Insight       Date:  2019-02-07

6.  TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt/β-catenin signaling.

Authors:  P-J Royer; K Henrio; M Pain; J Loy; A Roux; A Tissot; P Lacoste; C Pison; S Brouard; A Magnan
Journal:  Respir Res       Date:  2017-12-13

Review 7.  Molecular imaging of pulmonary diseases.

Authors:  Julien Dimastromatteo; Eric J Charles; Victor E Laubach
Journal:  Respir Res       Date:  2018-01-24

8.  Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.

Authors:  Richard Danger; Pierre-Joseph Royer; Damien Reboulleau; Eugénie Durand; Jennifer Loy; Adrien Tissot; Philippe Lacoste; Antoine Roux; Martine Reynaud-Gaubert; Carine Gomez; Romain Kessler; Sacha Mussot; Claire Dromer; Olivier Brugière; Jean-François Mornex; Romain Guillemain; Marcel Dahan; Christiane Knoop; Karine Botturi; Aurore Foureau; Christophe Pison; Angela Koutsokera; Laurent P Nicod; Sophie Brouard; Antoine Magnan
Journal:  Front Immunol       Date:  2018-01-11       Impact factor: 7.561

9.  Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.

Authors:  Hrishikesh S Kulkarni; Kevin Tsui; Suraj Sunder; Alex Ganninger; Laneshia K Tague; Chad A Witt; Derek E Byers; Elbert P Trulock; Ruben Nava; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Andrew E Gelman; Ramsey R Hachem
Journal:  Am J Transplant       Date:  2019-12-24       Impact factor: 8.086

10.  COMP: A Potential Early Biomarker of RAS After Lung Transplantation.

Authors:  Mirza Novo; Johan Westin; Lars-Magnus Andersson; Anton Jonsson Berdenius; Rickard Nordén; Jasper M Magnusson
Journal:  Transplant Direct       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.